Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hromas, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hromas, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

Blood, 15 February 2001, Vol. 97, No. 4, pp. 833-833

Receptor trees in chemokine forests

Chemokines are small proteins that direct the migration of all leukocyte classes. One would think that 2 or 3 distinct chemokines would be sufficient to ensure that white blood cells properly home to sites of inflammation. But there are at least 40 chemokines and 18 receptors, with new ones still being discovered. Surprisingly, many of the chemokines bind several receptors, and receptors are often promiscuous, being activated by many different chemokines. Chemokine receptor function has been obscured by the multitude of potential inteactions that all appear to lack distinct activities. Why are so many chemokines binding to so many receptors?

Weber et al (page 1144) provide an answer: activating different receptors produces distinct functions. Although this might seem obvious, the concept has been extremely difficult to prove. Leukocytes migrate from the bloodstream to inflamed tissue in 4 distinct steps: rolling along the vessel wall, arrest, spreading, and finally migration through the endothelium. Weber et al found that during this process the chemokine RANTES activates 2 different receptors, CCR1 and CCR5. They found that CCR1 activation was responsible for arrest in shear flow, while CCR5 contributed to spreading of the cell along the vessel wall. Both receptors contributed to movement through the endothelium.

Why is this important? Chemokine receptors play extremely important roles in human disease, from HIV infection to cardiovascular disease to autoimmune disorders. Previously it was thought that to inhibit chemokine contributions to disease one would have to target a large number of receptors. The present study raises the possibility that single receptors on specific cell types can be targeted to antagonize specific steps in pathologic leukocyte migration. Further analysis of narrow functional differences of chemokine receptors will help realize their enormous therapeutic potential.


---Robert Hromas
Indiana University Medical Center


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
B. Savoldo, M. H. Huls, Z. Liu, T. Okamura, H.-D. Volk, P. Reinke, R. Sabat, N. Babel, J. F. Jones, J. Webster-Cyriaque, et al.
Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection
Blood, December 1, 2002; 100(12): 4059 - 4066.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hromas, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hromas, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020